Huiyu Pharmaceutical(SH:688553) Xin Lang Cai Jing·2025-08-26 02:00Summary of Key Points Core Viewpoint - On August 25, Huayu Pharmaceutical experienced an 8.92% increase in stock price with a trading volume of 515 million yuan, indicating strong market interest and activity in the company's shares [1]. Financing and Trading Activity - On the same day, Huayu Pharmaceutical had a financing purchase amount of 50.95 million yuan, while the financing repayment was 68.19 million yuan, resulting in a net financing outflow of 17.25 million yuan [1]. - As of August 25, the total balance of margin trading for Huayu Pharmaceutical was 243 million yuan, which represents 2.56% of its market capitalization and is above the 80th percentile of the past year, indicating a high level of financing activity [1]. - In terms of securities lending, there were no shares sold or repaid on August 25, with a lending balance of 0 shares, placing it in the 90th percentile of the past year, also indicating a high level of activity [1]. Company Overview - Huayu Pharmaceutical, established on October 12, 2010, and listed on October 26, 2021, is located in Neijiang, Sichuan Province. The company specializes in the research, production, and sales of drugs in the oncology field and complex injectable drugs [1]. - The main revenue sources for Huayu Pharmaceutical include: Oxaliplatin injection (33.22%), other products (31.17%), injectable pemetrexed disodium (19.27%), injectable azacitidine (12.49%), technical service fees (3.03%), and other (0.82%) [1]. Financial Performance - As of March 31, the number of shareholders for Huayu Pharmaceutical was 18,400, an increase of 4.80% from the previous period, while the average circulating shares per person decreased by 4.58% to 16,791 shares [2]. - For the first quarter of 2025, Huayu Pharmaceutical reported a revenue of 239 million yuan, a year-on-year decrease of 1.46%, and a net profit attributable to shareholders of -25.63 million yuan, a significant decline of 155.19% year-on-year [2]. Dividend and Institutional Holdings - Since its A-share listing, Huayu Pharmaceutical has distributed a total of 474 million yuan in dividends, with 385 million yuan distributed over the past three years [3]. - As of March 31, 2025, the top ten circulating shareholders of Huayu Pharmaceutical saw the exit of E Fund Medical Healthcare Industry Mixed A (110023) from the list [3].